Streamline Health Solutions Stock Performance
| STRM Stock | USD 2.78 0.26 8.55% |
The entity has a beta of 1.15, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Streamline Health will likely underperform. At this point, Streamline Health has a negative expected return of -0.84%. Please make sure to validate Streamline Health's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Streamline Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Streamline Health Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (8.55) | Five Day Return (7.02) | Year To Date Return (57.88) | Ten Year Return (95.45) | All Time Return (98.79) |
Last Split Factor 1:15 | Last Split Date 2024-10-04 |
1 | Streamline Health Reports Fiscal Second Quarter 2024 Financial Results | 09/11/2024 |
2 | Streamline Health Solutions, Inc. Q2 2024 Earnings Call Transcript | 09/13/2024 |
3 | Acquisition by Tamarack Global Healthcare Fund, L.p. of 625000 shares of Streamline Health at 1.6 subject to Rule 16b-3 | 09/18/2024 |
4 | Acquisition by Ben Stilwill of 6300 shares of Streamline Health at 0.16 subject to Rule 16b-3 | 09/20/2024 |
5 | Streamline Health Announces Reverse Split, Adjusts Securities | 09/27/2024 |
6 | Streamline Health Debuts eValuator Quality Module | 10/08/2024 |
7 | Streamline Health Announces New eValuator Contract With Texas-Based Health System | 11/05/2024 |
8 | Light-it Launches CompliantChatGPT v2 Advanced AI Solutions to Reduce Medical Burden and Streamline Healthcare Workflows - Markets Insider | 11/21/2024 |
9 | Acquisition by Wendy Lovvorn of 170000 shares of Streamline Health at 1.75 subject to Rule 16b-3 | 11/22/2024 |
| Begin Period Cash Flow | 6.6 M |
Streamline |
Streamline Health Relative Risk vs. Return Landscape
If you would invest 727.00 in Streamline Health Solutions on August 31, 2024 and sell it today you would lose (449.00) from holding Streamline Health Solutions or give up 61.76% of portfolio value over 90 days. Streamline Health Solutions is currently does not generate positive expected returns and assumes 11.0677% risk (volatility on return distribution) over the 90 days horizon. In different words, 98% of stocks are less volatile than Streamline, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Streamline Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Streamline Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Streamline Health Solutions, and traders can use it to determine the average amount a Streamline Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0763
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STRM |
Estimated Market Risk
| 11.07 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.84 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Streamline Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Streamline Health by adding Streamline Health to a well-diversified portfolio.
Streamline Health Fundamentals Growth
Streamline Stock prices reflect investors' perceptions of the future prospects and financial health of Streamline Health, and Streamline Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Streamline Stock performance.
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.93) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | 20.66 M | ||||
| Shares Outstanding | 4.22 M | ||||
| Price To Earning | 321.67 X | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 0.58 X | ||||
| Revenue | 22.6 M | ||||
| Gross Profit | 11.49 M | ||||
| EBITDA | (12.82 M) | ||||
| Net Income | (18.7 M) | ||||
| Cash And Equivalents | 5.92 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 10.57 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 0.76 X | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | (2.21 M) | ||||
| Earnings Per Share | (4.80) X | ||||
| Market Capitalization | 11.74 M | ||||
| Total Asset | 41.73 M | ||||
| Retained Earnings | (115.7 M) | ||||
| Working Capital | (4.85 M) | ||||
| Current Asset | 16.2 M | ||||
| Current Liabilities | 14.11 M | ||||
About Streamline Health Performance
By examining Streamline Health's fundamental ratios, stakeholders can obtain critical insights into Streamline Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Streamline Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.77) | (1.68) | |
| Return On Capital Employed | (0.70) | (0.67) | |
| Return On Assets | (0.45) | (0.43) | |
| Return On Equity | (0.99) | (0.94) |
Things to note about Streamline Health performance evaluation
Checking the ongoing alerts about Streamline Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Streamline Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Streamline Health generated a negative expected return over the last 90 days | |
| Streamline Health has high historical volatility and very poor performance | |
| Streamline Health has high likelihood to experience some financial distress in the next 2 years | |
| Streamline Health Solutions currently holds 10.57 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Streamline Health has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Streamline Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 22.6 M. Net Loss for the year was (18.7 M) with profit before overhead, payroll, taxes, and interest of 11.49 M. | |
| Streamline Health Solutions currently holds about 5.92 M in cash with (2.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 24.0% of Streamline Health outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Light-it Launches CompliantChatGPT v2 Advanced AI Solutions to Reduce Medical Burden and Streamline Healthcare Workflows - Markets Insider |
- Analyzing Streamline Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Streamline Health's stock is overvalued or undervalued compared to its peers.
- Examining Streamline Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Streamline Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Streamline Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Streamline Health's stock. These opinions can provide insight into Streamline Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (4.80) | Revenue Per Share 5.249 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.